SG159550A1 - Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent - Google Patents

Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

Info

Publication number
SG159550A1
SG159550A1 SG201000998-3A SG2010009983A SG159550A1 SG 159550 A1 SG159550 A1 SG 159550A1 SG 2010009983 A SG2010009983 A SG 2010009983A SG 159550 A1 SG159550 A1 SG 159550A1
Authority
SG
Singapore
Prior art keywords
sequestering agent
metered dose
aerosol formulations
dose inhalers
pressurized metered
Prior art date
Application number
SG201000998-3A
Other languages
English (en)
Inventor
David Andrew Lewis
Brian John Meakin
Maurizio Delcanale
Fausto Pivetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36490097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG159550(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of SG159550A1 publication Critical patent/SG159550A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
SG201000998-3A 2005-02-25 2006-02-13 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent SG159550A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05004233 2005-02-25

Publications (1)

Publication Number Publication Date
SG159550A1 true SG159550A1 (en) 2010-03-30

Family

ID=36490097

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201000998-3A SG159550A1 (en) 2005-02-25 2006-02-13 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

Country Status (23)

Country Link
US (1) US8877164B2 (es)
EP (1) EP1850831B1 (es)
JP (1) JP5259193B2 (es)
KR (1) KR101313959B1 (es)
CN (1) CN101119706B (es)
AR (2) AR054230A1 (es)
AU (1) AU2006218177B2 (es)
BR (1) BRPI0607990A2 (es)
CA (1) CA2594127C (es)
EA (1) EA013405B1 (es)
GE (1) GEP20105040B (es)
HK (1) HK1116337A1 (es)
IL (1) IL184449A0 (es)
MA (1) MA29333B1 (es)
MX (1) MX2007010396A (es)
NO (1) NO20074854L (es)
NZ (1) NZ556376A (es)
PE (1) PE20061011A1 (es)
SG (1) SG159550A1 (es)
TN (1) TNSN07289A1 (es)
UA (1) UA92732C2 (es)
WO (1) WO2006089656A2 (es)
ZA (1) ZA200706870B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2565747A1 (en) * 2004-05-13 2005-12-01 Chiesi Farmaceutici S.P.A. Medicinal aerosol formulation products with improved chemical stability
GB201200525D0 (en) * 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
RU2519653C1 (ru) * 2013-02-27 2014-06-20 Шолекс Девелопмент Гмбх, Аэрозольный препарат на основе ипратропия бромида для лечения заболеваний органов дыхания
US10034866B2 (en) * 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US11642372B2 (en) 2020-05-01 2023-05-09 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US11826382B2 (en) 2020-05-01 2023-11-28 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US12042514B2 (en) 2020-05-01 2024-07-23 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA939195B (en) * 1992-12-09 1995-06-08 Boehringer Ingelheim Pharma Stabilized medicinal aerosol solution formulations
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
DK0735884T3 (da) 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolid-aerosolformuleringer
WO1996040042A2 (en) * 1995-06-07 1996-12-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Stabilized steroid compositions
ES2183001T3 (es) * 1995-06-27 2003-03-16 Boehringer Ingelheim Pharma Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
WO2001087203A1 (en) * 2000-05-17 2001-11-22 Chrysalis Technologies Incorporated Stabilized budesonide solution and method for making same
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
MXPA04008372A (es) * 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
BR0309185A (pt) 2002-04-12 2005-02-15 Boehringer Ingelheim Pharma Medicamento contendo beta-miméticos e um novo anticolinérgico
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
DE10230769A1 (de) 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
WO2004033478A2 (en) * 2002-10-08 2004-04-22 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
EA013405B1 (ru) 2010-04-30
BRPI0607990A2 (pt) 2009-10-27
CA2594127C (en) 2013-10-15
EP1850831A2 (en) 2007-11-07
KR20070107002A (ko) 2007-11-06
AR054230A1 (es) 2007-06-13
AU2006218177B2 (en) 2012-04-12
MX2007010396A (es) 2007-10-19
US20060193785A1 (en) 2006-08-31
CA2594127A1 (en) 2006-08-31
JP5259193B2 (ja) 2013-08-07
IL184449A0 (en) 2007-10-31
JP2008537729A (ja) 2008-09-25
KR101313959B1 (ko) 2013-10-02
WO2006089656A3 (en) 2006-12-21
AR099963A2 (es) 2016-08-31
EP1850831B1 (en) 2015-12-02
EA200701805A1 (ru) 2008-02-28
ZA200706870B (en) 2008-11-26
CN101119706B (zh) 2013-04-17
NZ556376A (en) 2010-01-29
MA29333B1 (fr) 2008-03-03
CN101119706A (zh) 2008-02-06
TNSN07289A1 (en) 2008-12-31
UA92732C2 (ru) 2010-12-10
NO20074854L (no) 2007-09-24
PE20061011A1 (es) 2006-12-08
AU2006218177A1 (en) 2006-08-31
GEP20105040B (en) 2010-07-12
WO2006089656A2 (en) 2006-08-31
HK1116337A1 (en) 2008-12-19
US8877164B2 (en) 2014-11-04

Similar Documents

Publication Publication Date Title
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
CY1121719T1 (el) Διαταξη ρινικου ψεκασμου
WO2007123945A3 (en) Mechanical single dose intrapulmonary drug delivery devices
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
NZ534040A (en) Metered dose inhaler
UY29905A1 (es) Formulación farmacéutica de absorción oral y su método de administración
EE200200649A (et) Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele
AR059350A1 (es) Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
WO2007020204A3 (en) Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
BR0107730A (pt) Inalador aerosol
ECSP088732A (es) Aerosoles dosificadores para la administración de preparaciones farmacéuticas
JO3024B1 (ar) صيغ أيروسول صيدلانية من الفرموتيرول وبكلوميتازون داي بروبيونات
HK1103280A1 (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ZA200606577B (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2004103339A3 (en) Improved metered dose inhaler
UA90346C2 (ru) Фармацевтическая рецептура для перорального приема и способ введения пациенту
AU2003215588A1 (en) Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery